Abstract:AbstractBackgroundNeuroinflammation plays an important role in cerebral ischemia/reperfusion (I/R) injury. The P2X7 receptor (P2X7R) has been reported to be involved in the inflammatory response of many central nervous system diseases. However, the role of P2X7Rs in transient global cerebral I/R injury remains unclear. The purpose of this study is to determine the effects of inhibiting the P2X7R in a rat model of transient global cerebral I/R injury, and then to explore the association between the P2X7R and neuroinflammation after transient global cerebral I/R injury.MethodsImmediately after infusion with the P2X7R antagonists Brilliant blue G (BBG), adenosine 5′-triphosphate-2′,3′-dialdehyde (OxATP) or A-438079, 20 minutes of transient global cerebral I/R was induced using the four-vessel occlusion (4-VO) method in rats. Survival rate was calculated, neuronal death in the hippocampal CA1 region was observed using H & E staining, and DNA cleavage was observed by deoxynucleotidyl transferase-mediated UTP nick end labeling TUNEL). In addition, behavioral deficits were measured using the Morris water maze, and RT-PCR and immunohistochemical staining were performed to measure the expression of IL-1β, TNF-α and IL-6, and to identify activated microglia and astrocytes.ResultsThe P2X7R antagonists protected against transient global cerebral I/R injury in a dosage-dependent manner. A high dosage of BBG (10 μg) and A-0438079 (3 μg), and a low dosage of OxATP (1 μg) significantly increased survival rates, reduced I/R-induced learning memory deficit, and reduced I/R-induced neuronal death, DNA cleavage, and glial activation and inflammatory cytokine overexpression in the hippocampus.ConclusionsOur study indicates that inhibiting P2X7Rs protects against transient global cerebral I/R injury by reducing the I/R-induced inflammatory response, which suggests inhibition of P2X7Rs may be a promising therapeutic strategy for clinical treatment of transient global cerebral I/R injury.

Research Progress in the Relationship Between P2X7 and Flavonoids in Cardiovascular Disease

Beneficial effects of flavonoids on cardiovascular diseases by influencing NLRP3 inflammasome

Flavonoids: Potential therapeutic agents for cardiovascular disease

Research Advances in Mechanism of Flavonoids Against Atherosclerosis

P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease

Research Progress of Flavonoids Regulating Endothelial Function

Naringenin and Naringin in Cardiovascular Disease Prevention: A Preclinical Review

Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases

From lead to clinic: A review of the structural design of P2X7R antagonists

Advances in Studies on Potential Toxicity of Flavonoids

Inhibition of P2X7 Receptor Ameliorates Transient Global Cerebral Ischemia/reperfusion Injury Via Modulating Inflammatory Responses in the Rat Hippocampus

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids

Flavonoids as potential anti-platelet aggregation agents: from biochemistry to health promoting abilities

The Effects of Flavonoids in Cardiovascular Diseases

Antiatherogenic properties of flavonoids: Implications for cardiovascular health

Research Progress on Bio-flavonoids As Natural Radioprotectant

Pulmonary arterial hypertension and flavonoids: A role in treatment

Research progress of quercetin in cardiovascular disease

Liquiritin: A natural flavonoid with potential cardiovascular protection

Protective Effects of Paeoniflorin on Cardiovascular Disease: A Pharmacological and Mechanistic Overview

Roles of flavonoids in ischemic heart disease: cardioprotective effects and mechanisms against myocardial ischemia and reperfusion injury